Work

Use of radiopharmaceuticals in the diagnosis of neurodegenerative diseases

Year: 2024

Type: article

Abstract: Neurodegenerative diseases are illnesses that affect the central nervous system (CNS) characterized by a series of symptoms such as dementia, motor disturbances , behavioural and psychological disorders, and cognitive impairments . The most common neurodegenerative disorders are Alzheimer's disease and Parkinson's disease , for which radiopharmaceuticals have been developed and approved for the purpose of PET investigation. Biomarkers are molecules that can be studied and used for diagnostic purposes, to monitor diseases, and to identify potential risk factors early.

Source: European Journal of Medicinal Chemistry Reports

DOI: 10.1016/j.ejmcr.2024.100239

Authors: Anna Tempesta, Anna Tolomeo, Azzurra Stefanucci, Lorenza Marinaccio, Adriano Mollica

Institution: University of Chieti-Pescara

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,500